Resveratrol downregulated the MTA1/HDAC unit of the NuRD complex and then promoted PTEN acetylation, thus blocking the PTEN/Akt pathway and inhibiting the progression of prostate cancer [15]. Here, MTA1 is linked to prostate carcinoma.